Ghana

Ghana

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
8.63 (7.19 - 10.34) 2015 Modelled WHO
8.36 2019 Modelled Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis
10.3 (6.90 - 11.40) 2016 Modelled Razavi-Shearer et al, 2018
12.3 (11.30 - 13.40) 2015 Modelled Ofori-Asenso and Agyeman, 2016
12.92 (12.44 - 13.42) 2013 Modelled Schweitzer et al, 2015
9.07 (8.28 - 9.92) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9.65 (8.84 - 10.38) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9.67 (8.83 - 10.49) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10.34 (9.48 - 11.12) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11.06 (10.06 - 11.94) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11.3 (10.32 - 12.14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11.7 (10.68 - 12.57) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.16 (11.10 - 13.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12.56 (11.41 - 13.61) 2011 Modelled IHME, GBD 2019 (accessed 2022)
12.79 (11.58 - 13.90) 2010 Modelled IHME, GBD 2019 (accessed 2022)
13.05 (11.87 - 14.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
13.51 (12.35 - 14.59) 2008 Modelled IHME, GBD 2019 (accessed 2022)
14.05 (12.86 - 15.14) 2007 Modelled IHME, GBD 2019 (accessed 2022)
14.52 (13.27 - 15.66) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14.79 (13.53 - 16.03) 2005 Modelled IHME, GBD 2019 (accessed 2022)
15.03 (13.78 - 16.22) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15.46 (14.15 - 16.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
15.94 (14.61 - 17.22) 2002 Modelled IHME, GBD 2019 (accessed 2022)
16.38 (14.97 - 17.73) 2001 Modelled IHME, GBD 2019 (accessed 2022)
16.63 (15.19 - 18.05) 2000 Modelled IHME, GBD 2019 (accessed 2022)
16.73 (15.39 - 18.16) 1999 Modelled IHME, GBD 2019 (accessed 2022)
16.83 (15.51 - 18.21) 1998 Modelled IHME, GBD 2019 (accessed 2022)
16.92 (15.63 - 18.29) 1997 Modelled IHME, GBD 2019 (accessed 2022)
17.02 (15.72 - 18.46) 1996 Modelled IHME, GBD 2019 (accessed 2022)
17.11 (15.78 - 18.58) 1995 Modelled IHME, GBD 2019 (accessed 2022)
17.22 (15.92 - 18.66) 1994 Modelled IHME, GBD 2019 (accessed 2022)
17.34 (16.03 - 18.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
17.47 (16.17 - 18.86) 1992 Modelled IHME, GBD 2019 (accessed 2022)
17.6 (16.25 - 19.01) 1991 Modelled IHME, GBD 2019 (accessed 2022)
17.74 (16.36 - 19.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9.65 (8.81 - 10.56) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.61 (2.50 - 5) 2015 Modelled WHO
0.55 2019 Modelled Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis
0.64 (0.50 - 0.80) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.71 (0.56 - 0.88) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.58 - 0.90) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.62 - 0.97) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.28) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.38 (1.10 - 1.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.30 - 1.95) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.47 - 2.18) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.97 (1.62 - 2.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.76 - 2.58) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.85 - 2.75) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.93 - 2.82) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.98 - 2.85) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (2.03 - 2.91) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.08 - 3.03) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.19 - 3.21) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (3.12 - 4.51) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.18 (5.11 - 7.41) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9.03 (7.49 - 10.79) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11.45 (9.43 - 13.74) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12.63 (10.38 - 15.23) 2000 Modelled IHME, GBD 2019 (accessed 2022)
12.86 (10.57 - 15.40) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13.01 (10.73 - 15.50) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13.13 (10.75 - 15.54) 1997 Modelled IHME, GBD 2019 (accessed 2022)
13.22 (10.79 - 15.64) 1996 Modelled IHME, GBD 2019 (accessed 2022)
13.32 (10.75 - 15.74) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13.44 (10.92 - 15.89) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13.55 (11.19 - 16.06) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13.67 (11.30 - 16.17) 1992 Modelled IHME, GBD 2019 (accessed 2022)
13.78 (11.43 - 16.24) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13.89 (11.57 - 16.31) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.13 (1.75 - 2.56) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
2,897,000 (1,938,000 - 3,227,000) 2016 Modelled Razavi-Shearer et al, 2018
2,860,620 (2,611,590 - 3,127,380) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,957,840 (2,700,170 - 3,230,340) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,893,150 (2,653,340 - 3,107,630) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,834,920 (2,589,420 - 3,075,920) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,966,290 (2,719,020 - 3,190,730) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,104,590 (2,832,460 - 3,352,020) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,099,960 (2,832,230 - 3,332,050) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,135,380 (2,862,050 - 3,371,980) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3,179,460 (2,896,060 - 3,422,640) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3,203,000 (2,904,860 - 3,469,550) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3,178,740 (2,876,300 - 3,456,670) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3,155,780 (2,869,460 - 3,417,430) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3,177,410 (2,901,880 - 3,430,940) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3,210,850 (2,939,390 - 3,457,130) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3,225,530 (2,948,930 - 3,483,700) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3,193,100 (2,921,640 - 3,463,290) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3,156,980 (2,894,990 - 3,407,190) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3,159,380 (2,892,930 - 3,415,160) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3,173,420 (2,906,400 - 3,424,810) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,174,180 (2,903,660 - 3,440,990) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,138,600 (2,865,410 - 3,407,280) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3,078,160 (2,827,200 - 3,344,890) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3,018,940 (2,779,860 - 3,264,500) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,961,540 (2,731,880 - 3,203,800) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,906,120 (2,687,740 - 3,151,010) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,852,880 (2,629,640 - 3,098,620) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,803,250 (2,592,960 - 3,034,430) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,757,260 (2,550,850 - 2,979,940) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,714,000 (2,509,390 - 2,926,620) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,672,830 (2,469,780 - 2,884,680) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,632,900 (2,428,560 - 2,845,850) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.89 (7.21 - 13.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
15.66 (11.10 - 22.15) 1991 Modelled IHME, GBD 2019 (accessed 2022)
15.58 (11.01 - 21.91) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15.82 (11.27 - 22.15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
15.94 (11.50 - 22.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15.93 (11.64 - 21.91) 1994 Modelled IHME, GBD 2019 (accessed 2022)
15.85 (11.66 - 21.69) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15.87 (11.78 - 21.56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
16.06 (12 - 21.28) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15.94 (12.09 - 20.88) 1998 Modelled IHME, GBD 2019 (accessed 2022)
15.78 (12.19 - 20.26) 1999 Modelled IHME, GBD 2019 (accessed 2022)
15.57 (12.09 - 19.58) 2000 Modelled IHME, GBD 2019 (accessed 2022)
15.33 (12.10 - 18.91) 2001 Modelled IHME, GBD 2019 (accessed 2022)
14.96 (11.73 - 18.39) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14.52 (11.35 - 17.81) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13.96 (11.02 - 17.03) 2005 Modelled IHME, GBD 2019 (accessed 2022)
13.66 (10.86 - 16.73) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14.17 (11.13 - 17.31) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13.37 (10.60 - 16.37) 2007 Modelled IHME, GBD 2019 (accessed 2022)
13.06 (10.29 - 15.98) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12.84 (10.10 - 15.61) 2009 Modelled IHME, GBD 2019 (accessed 2022)
12.72 (9.93 - 15.51) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12.43 (9.71 - 15.13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11.81 (9.24 - 14.58) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10.49 (8.15 - 13.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11.08 (8.63 - 13.80) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10.14 (7.74 - 12.94) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10.11 (7.64 - 13.12) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10.17 (7.60 - 13.40) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9.95 (7.38 - 13.29) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9.89 (7.21 - 13.17) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
5,108 2016 Modelled WHO
2,408 (1,706 - 3,405) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,339 (1,653 - 3,291) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,569 (1,853 - 3,559) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,490 (1,774 - 3,486) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,629 (1,921 - 3,615) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,680 (1,972 - 3,666) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,903 (2,201 - 3,801) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,749 (2,041 - 3,734) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,851 (2,130 - 3,778) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,949 (2,278 - 3,785) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,986 (2,320 - 3,755) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3,021 (2,384 - 3,726) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,029 (2,375 - 3,723) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,034 (2,382 - 3,705) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3,022 (2,362 - 3,707) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3,093 (2,459 - 3,788) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3,074 (2,427 - 3,748) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3,113 (2,469 - 3,814) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3,127 (2,464 - 3,826) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3,162 (2,487 - 3,842) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3,217 (2,512 - 3,924) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3,228 (2,522 - 3,929) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3,148 (2,462 - 3,888) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3,030 (2,360 - 3,775) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,943 (2,286 - 3,706) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,975 (2,249 - 3,861) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,913 (2,224 - 3,718) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,065 (2,289 - 4,036) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,069 (2,274 - 4,098) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,118 (2,273 - 4,155) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,118 (2,273 - 4,155) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
14 (11 - 19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 1994 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1995 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1998 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1997 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 1999 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 2000 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2001 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2002 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2003 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2004 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2005 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2006 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2007 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2009 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2010 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2013 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2014 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 27) 2015 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2019 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 31) 2018 Modelled IHME, GBD 2019 (accessed 2022)
51 (42 - 60) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2019 Survey/reported WHO/UNICEF
94 2020 Survey/reported WHO/UNICEF
98 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.5 (0.90 - 4.10) 2015 Modelled Maaroufi et al, 2017
1.4 (1.10 - 3.40) 2017 Modelled Sonderup et al, 2017
1.4 (1.10 - 3.40) 2015 Modelled Blach et al, 2017
3.44 (2.75 - 4.35) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3.45 (2.76 - 4.35) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.45 (2.77 - 4.37) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.45 (2.78 - 4.32) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.46 (2.77 - 4.33) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.48 (2.79 - 4.35) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (2.82 - 4.42) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.85 - 4.44) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.61 (2.90 - 4.51) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (2.94 - 4.59) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (2.99 - 4.60) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.73 (3.02 - 4.64) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.78 (3.06 - 4.69) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.09 - 4.70) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (3.12 - 4.74) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.22 - 4.80) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.07 (3.35 - 4.86) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.48 - 4.94) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.58 - 5.07) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.37 (3.64 - 5.16) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.42 (3.68 - 5.22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.72 - 5.27) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.52 (3.75 - 5.36) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (3.76 - 5.40) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.75 - 5.43) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.75 - 5.42) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.56 (3.73 - 5.42) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (3.72 - 5.44) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.53 (3.68 - 5.44) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.5 (3.65 - 5.45) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.33 (2.65 - 4.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.83 (1.40 - 4.33) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.2 (0.50 - 8.10) 2014 Modelled Riou et al, 2015
2 (1.20 - 5.50) 2014 Modelled Maaroufi et al, 2017
3 (2.60 - 3.50) 2015 Modelled Agyeman et al, 2016
3.2 (0.50 - 8.10) 2017 Modelled Sonderup et al, 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
40.1 (34.80 - 45.40) 2005 Survey/reported Adjei A et al, 2007
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
399,000 (305,000 - 944,000) 2015 Modelled Blach et al, 2017
668,520 (540,666 - 808,090) 1990 Modelled IHME, GBD 2019 (accessed 2022)
688,198 (558,406 - 825,600) 1991 Modelled IHME, GBD 2019 (accessed 2022)
707,153 (577,752 - 846,073) 1992 Modelled IHME, GBD 2019 (accessed 2022)
725,556 (593,333 - 863,435) 1993 Modelled IHME, GBD 2019 (accessed 2022)
743,530 (610,290 - 881,899) 1994 Modelled IHME, GBD 2019 (accessed 2022)
761,276 (625,401 - 906,294) 1995 Modelled IHME, GBD 2019 (accessed 2022)
777,573 (642,356 - 922,786) 1996 Modelled IHME, GBD 2019 (accessed 2022)
791,315 (656,604 - 936,600) 1997 Modelled IHME, GBD 2019 (accessed 2022)
803,147 (668,018 - 946,391) 1998 Modelled IHME, GBD 2019 (accessed 2022)
813,816 (678,218 - 960,377) 1999 Modelled IHME, GBD 2019 (accessed 2022)
824,069 (687,341 - 973,649) 2000 Modelled IHME, GBD 2019 (accessed 2022)
830,783 (693,164 - 981,480) 2001 Modelled IHME, GBD 2019 (accessed 2022)
832,217 (692,302 - 983,648) 2002 Modelled IHME, GBD 2019 (accessed 2022)
831,586 (685,418 - 994,137) 2003 Modelled IHME, GBD 2019 (accessed 2022)
832,505 (676,945 - 1,007,580) 2004 Modelled IHME, GBD 2019 (accessed 2022)
839,022 (674,798 - 1,023,080) 2005 Modelled IHME, GBD 2019 (accessed 2022)
850,644 (687,876 - 1,042,590) 2006 Modelled IHME, GBD 2019 (accessed 2022)
863,723 (700,770 - 1,072,180) 2007 Modelled IHME, GBD 2019 (accessed 2022)
877,818 (710,290 - 1,092,100) 2008 Modelled IHME, GBD 2019 (accessed 2022)
892,413 (721,673 - 1,114,250) 2009 Modelled IHME, GBD 2019 (accessed 2022)
906,886 (730,949 - 1,139,520) 2010 Modelled IHME, GBD 2019 (accessed 2022)
919,711 (739,533 - 1,148,860) 2011 Modelled IHME, GBD 2019 (accessed 2022)
930,889 (745,663 - 1,162,850) 2012 Modelled IHME, GBD 2019 (accessed 2022)
942,008 (753,743 - 1,183,880) 2013 Modelled IHME, GBD 2019 (accessed 2022)
954,828 (764,663 - 1,193,070) 2014 Modelled IHME, GBD 2019 (accessed 2022)
971,284 (777,368 - 1,213,900) 2015 Modelled IHME, GBD 2019 (accessed 2022)
990,836 (796,382 - 1,240,190) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,012,360 (810,304 - 1,279,540) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,034,200 (830,030 - 1,303,150) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,048,760 (837,177 - 1,324,580) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,055,200 (843,069 - 1,332,320) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
138,000 (106,000 - 328,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
1.75 (1.23 - 2.42) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.24 (1.50 - 3.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.49 - 3.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.50 - 3.16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.49 - 3.12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.2 (1.50 - 3.12) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.49 - 3.08) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.55 - 2.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.50 - 3.06) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.54 - 3.02) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.17 (1.56 - 2.95) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.56 - 2.92) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.53 - 2.85) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.50 - 2.78) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.45 - 2.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.42 - 2.63) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.35 - 2.51) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.39 - 2.57) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.31 - 2.44) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.29 - 2.41) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.27 - 2.36) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.26 - 2.35) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.25 - 2.36) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.25 - 2.35) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.27 - 2.43) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.27 - 2.43) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.27 - 2.37) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.29 - 2.53) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.27 - 2.48) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.23 - 2.42) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.24 - 2.46) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,090 2016 Modelled WHO
552 (387 - 764) 2019 Modelled IHME, GBD 2019 (accessed 2022)
552 (387 - 764) 2019 Modelled IHME, GBD 2019 (accessed 2020)
548 (383 - 758) 2018 Modelled IHME, GBD 2019 (accessed 2022)
548 (388 - 762) 2017 Modelled IHME, GBD 2019 (accessed 2022)
529 (375 - 731) 2016 Modelled IHME, GBD 2019 (accessed 2022)
513 (364 - 699) 2015 Modelled IHME, GBD 2019 (accessed 2022)
500 (358 - 681) 2014 Modelled IHME, GBD 2019 (accessed 2022)
481 (347 - 647) 2013 Modelled IHME, GBD 2019 (accessed 2022)
465 (333 - 631) 2012 Modelled IHME, GBD 2019 (accessed 2022)
451 (324 - 610) 2011 Modelled IHME, GBD 2019 (accessed 2022)
441 (318 - 595) 2010 Modelled IHME, GBD 2019 (accessed 2022)
433 (312 - 580) 2009 Modelled IHME, GBD 2019 (accessed 2022)
426 (308 - 577) 2008 Modelled IHME, GBD 2019 (accessed 2022)
421 (304 - 569) 2007 Modelled IHME, GBD 2019 (accessed 2022)
419 (306 - 568) 2006 Modelled IHME, GBD 2019 (accessed 2022)
419 (306 - 566) 2005 Modelled IHME, GBD 2019 (accessed 2022)
416 (305 - 562) 2004 Modelled IHME, GBD 2019 (accessed 2022)
414 (302 - 563) 2003 Modelled IHME, GBD 2019 (accessed 2022)
414 (303 - 563) 2002 Modelled IHME, GBD 2019 (accessed 2022)
413 (302 - 562) 2001 Modelled IHME, GBD 2019 (accessed 2022)
412 (298 - 560) 2000 Modelled IHME, GBD 2019 (accessed 2022)
405 (292 - 551) 1999 Modelled IHME, GBD 2019 (accessed 2022)
398 (282 - 540) 1998 Modelled IHME, GBD 2019 (accessed 2022)
392 (273 - 536) 1997 Modelled IHME, GBD 2019 (accessed 2022)
379 (259 - 530) 1996 Modelled IHME, GBD 2019 (accessed 2022)
370 (253 - 521) 1995 Modelled IHME, GBD 2019 (accessed 2022)
363 (247 - 514) 1994 Modelled IHME, GBD 2019 (accessed 2022)
357 (240 - 503) 1993 Modelled IHME, GBD 2019 (accessed 2022)
351 (235 - 497) 1992 Modelled IHME, GBD 2019 (accessed 2022)
344 (230 - 490) 1991 Modelled IHME, GBD 2019 (accessed 2022)
338 (223 - 487) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
4 (3 - 6) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 8) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2022)
14 (9 - 19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
3,118
2019
(2,273 - 4,155)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
552
2019
(387 - 764)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines